MCB Accepts, published online ahead of print on 26 October 2009
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Li, C.
Right arrow Articles by Enders, G. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, C.
Right arrow Articles by Enders, G. H.

 Previous Article  |  Next Article 

Mol. Cell. Biol. doi:10.1128/MCB.01876-08
Copyright (c) 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

A bi-functional regulatory element in human somatic Wee1 mediates cyclin A/Cdk2 binding and Crm1-dependent nuclear export

Changqing Li, Mark Andrake, Roland Dunbrack, and Greg H. Enders*

Department of Medicine, Epigenetics and Progenitor Cell Keystone Program, Fox Chase Cancer Center, Philadelphia, PA; Program in Molecular and Translational Medicine, Fox Chase Cancer Center, Philadelphia, PA

* To whom correspondence should be addressed. Email: Greg.Enders{at}fccc.edu.


arrow
Abstract

Sophisticated models for the regulation of mitotic entry are lacking for human cells. Inactivating human cyclin A/Cdk2 complexes through diverse approaches delays mitotic entry and promotes inhibitory phosphorylation of Cdk1 on tyrosine 15, a modification performed by Wee1. We show here that cyclin A/Cdk2 complexes physically associate with Wee1 in U2OS cells. Mutation of four conserved RxL cyclin A/Cdk binding motifs in Wee1 diminished stable binding. RxL1 resides within a large regulatory region of Wee1 that is predicted to be intrinsically disordered (residues 1-292). Near RxL1 is T239, a site of inhibitory Cdk phosphorylation in Xenopus Wee1 proteins. We found that T239 is phosphorylated in human Wee1 and that this phosphorylation was reduced in an RxL1 mutant. RxL1 and T239 mutants each mediated greater Cdk phosphorylation and G2/M inhibition than wild type, suggesting that cyclin A/Cdk complexes inhibit human Wee1 through these sites. The RxL1 mutant uniquely also displayed increased nuclear localization. RxL1 is embedded within sequences homologous to Crm1-dependent nuclear export signals (NESs). Co-immunoprecipitation showed that Crm1 associated with Wee1. Moreover, treatment with the Crm1 inhibitor Leptomycin B or independent mutation of the potential NES (NESm) abolished Wee1 nuclear export. Export was also reduced by Cdk inhibition or cyclin A RNAi, suggesting that cyclin A/Cdk complexes contribute to Wee1 export. Somewhat surprisingly, NESm did not display increased G2/M inhibition. Thus, nuclear export of Wee1 is not essential for mitotic entry, though an important functional role remains likely. These studies identify a novel bi-functional regulatory element in Wee1 that mediates cyclin A/Cdk2 association and nuclear export.